Biosynex S.A.
PAR: ALBIO.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Larry Abensur
- Employees
- 515
- Headquarters
- Illkirch-Graffenstaden, France
- IPO year
- 2011
- Market cap
- €20.3M
- Website
- https://www.biosynex.com
Loading ALBIO…
Loading profile data…Frequently asked questions about ALBIO
What does Biosynex S.A. (ALBIO.PA) do?
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers a range of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncolog...
Where does ALBIO.PA trade?
Biosynex S.A. (ALBIO.PA) trades on the Euronext Paris.
What sector is ALBIO.PA in?
Biosynex S.A. (ALBIO.PA) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Biosynex S.A.?
Larry Abensur is the chief executive officer of Biosynex S.A. (ALBIO.PA).
Where is Biosynex S.A. headquartered?
Biosynex S.A. is headquartered in France.
Does ALBIO.PA pay a dividend?
Biosynex S.A. (ALBIO.PA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALBIO.PA go public?
Biosynex S.A. (ALBIO.PA) completed its initial public offering in 2011.